Cyclerion Therapeutics (CYCN) Exchange Rate Effect (2019 - 2024)
Cyclerion Therapeutics (CYCN) posted quarterly Exchange Rate Effect of -$2000.0 for Q2 2024, down 166.67% year-over-year from $3000.0 in Q3 2023, and up 50.0% quarter-over-quarter from -$4000.0 in Q1 2024.
Cyclerion Therapeutics (CYCN) Exchange Rate Effect (2019 - 2024) Analysis & Trends
Cyclerion Therapeutics' Exchange Rate Effect history runs 6 years deep, the most recent figure standing at -$2000.0 for Q2 2024.
- In Q2 2024, Exchange Rate Effect fell 166.67% year-over-year to -$2000.0; the TTM figure through Mar 2025 stood at -$2000.0 (down 166.67% YoY), while the FY2024 annual figure was -$6000.0, down 175.0% from the prior year.
- Exchange Rate Effect for Q2 2024 stood at -$2000.0, up from -$4000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $8000.0 in Q4 2022, with the low at -$12000.0 in Q2 2020.
- The 5-year median for Exchange Rate Effect is $1000.0 (2021), against an average of $142.86.
- The sharpest annual moves came in 2023 and 2024: Exchange Rate Effect surged 400.0% in 2023, then sank 500.0% in 2024.
- Cyclerion Therapeutics' Exchange Rate Effect stood at $3000.0 in 2020, then changed by 0.0% to $3000.0 in 2021, then surged by 166.67% to $8000.0 in 2022, then slumped by 50.0% to $4000.0 in 2023, then slumped by 150.0% to -$2000.0 in 2024.
- Business Quant data shows CYCN's Exchange Rate Effect at -$2000.0 in Q2 2024, -$4000.0 in Q1 2024, and $4000.0 in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | Cyclerion Therapeutics | 12.48 Mn | 9.24 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -2,000.00 |
| Jun 30, 2024 | -2,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Mar 31, 2024 | -4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Dec 31, 2023 | 4,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Jun 30, 2023 | 3,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Dec 31, 2022 | 8,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Sep 30, 2022 | -3,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Jun 30, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Mar 31, 2022 | -1,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Dec 31, 2021 | 3,000.00 |